全文获取类型
收费全文 | 1679篇 |
免费 | 87篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 36篇 |
妇产科学 | 20篇 |
基础医学 | 411篇 |
口腔科学 | 12篇 |
临床医学 | 163篇 |
内科学 | 295篇 |
皮肤病学 | 5篇 |
神经病学 | 60篇 |
特种医学 | 70篇 |
外科学 | 487篇 |
综合类 | 19篇 |
预防医学 | 28篇 |
眼科学 | 65篇 |
药学 | 52篇 |
中国医学 | 1篇 |
肿瘤学 | 40篇 |
出版年
2022年 | 14篇 |
2021年 | 16篇 |
2020年 | 17篇 |
2019年 | 34篇 |
2018年 | 28篇 |
2017年 | 16篇 |
2016年 | 17篇 |
2015年 | 34篇 |
2014年 | 47篇 |
2013年 | 54篇 |
2012年 | 62篇 |
2011年 | 79篇 |
2010年 | 58篇 |
2009年 | 51篇 |
2008年 | 63篇 |
2007年 | 69篇 |
2006年 | 50篇 |
2005年 | 53篇 |
2004年 | 75篇 |
2003年 | 48篇 |
2002年 | 55篇 |
2001年 | 46篇 |
2000年 | 47篇 |
1999年 | 60篇 |
1998年 | 24篇 |
1997年 | 20篇 |
1996年 | 13篇 |
1993年 | 12篇 |
1992年 | 16篇 |
1990年 | 13篇 |
1988年 | 16篇 |
1987年 | 14篇 |
1986年 | 15篇 |
1985年 | 15篇 |
1984年 | 12篇 |
1974年 | 12篇 |
1973年 | 13篇 |
1971年 | 17篇 |
1966年 | 14篇 |
1965年 | 12篇 |
1935年 | 16篇 |
1934年 | 34篇 |
1931年 | 16篇 |
1930年 | 15篇 |
1929年 | 12篇 |
1926年 | 12篇 |
1925年 | 25篇 |
1924年 | 27篇 |
1923年 | 40篇 |
1922年 | 28篇 |
排序方式: 共有1768条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
35.
36.
37.
The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Chatterjee M Rancso C Stühmer T Eckstein N Andrulis M Gerecke C Lorentz H Royer HD Bargou RC 《Blood》2008,111(7):3714-3722
Current knowledge about molecular mechanisms underlying disease progression and drug resistance in multiple myeloma (MM) is still limited. Here, we analyzed the potential pathogenetic role of the Y-box binding protein YB-1 in MM. YB-1 is a member of the cold-shock domain protein superfamily and involved in various cellular functions such as proliferation. Immunohistochemical analyses revealed that neither normal bone marrow (BM) plasma cells (PCs), premalignant PCs of patients with monoclonal gammopathy of unknown significance (MGUS), nor MM cells with a mature morphology showed expression of YB-1 in situ. In contrast, YB-1 was strongly expressed in situ in normal PC precursor blasts as well as in a MM subset and in vitro in all of the evaluated MM cell lines. The YB-1-expressing MM cells were characterized by an immature morphology and a highly proliferative phenotype as defined by Ki 67 expression. We observed that siRNA-mediated knockdown of YB-1 decreased proliferation and induced apoptosis in MM cells even in the presence of BM stromal cells. Furthermore, we found that overexpression of YB-1 mediated resistance toward doxorubicin-induced apoptosis in MM cells. Thus, YB-1 contributes to disease progression, survival, and drug resistance in MM and might therefore provide an attractive therapeutic target. 相似文献
38.
Venigalla RK Tretter T Krienke S Max R Eckstein V Blank N Fiehn C Ho AD Lorenz HM 《Arthritis and rheumatism》2008,58(7):2120-2130
OBJECTIVE: CD4+,CD25high regulatory T (Treg) cells play a crucial role in the maintenance of self tolerance and prevention of organ-specific autoimmunity. The presence of many in vivo-preactivated CD4+,CD25++ T cells in patients with systemic lupus erythematosus (SLE) poses a difficulty in discriminating CD25++ activated T cells from CD25high Treg cells. To overcome this problem, we analyzed the phenotype and function of CD4+,CD25high,CD127(-/low) natural Treg (nTreg) cells isolated from the peripheral blood of patients with SLE. METHODS: CD4+,CD25high,CD127(-/low) nTreg cells and CD4+,CD25- responder T (Tresp) cells from patients with SLE and normal donors were separated by fluorescence-activated cell sorting. Cell proliferation was quantified by 3H-thymidine incorporation, and immunophenotyping of the cells was done using FACScan. RESULTS: Comparable percentages of CD4+,CD25high,FoxP3+ T cells were observed in patients with SLE and normal donors. Proliferation of SLE nTreg cells sorted into the subset CD4+,CD25high,CD127(-/low) was significantly decreased compared with that of SLE nTreg cells sorted into the subset CD4+,CD25high (mean +/- SEM 2,223 +/- 351 counts per minute versus 9,104 +/- 1,720 cpm, respectively), while in normal donors, these values were 802 +/- 177 cpm and 2,028 +/- 548 cpm, respectively, confirming that effector cell contamination was reduced. Notably, the suppressive activity of nTreg cells was intact in all groups. However, CD4+,CD25- Tresp cells isolated from patients with active SLE were significantly less sensitive than those from patients with inactive SLE to the suppressive function of autologous or normal donor CD4+,CD25high,CD127(-/low) nTreg cells. Furthermore, a significant inverse correlation was observed between the extent of T cell regulation in suppressor assays and the level of lupus disease activity. CONCLUSION: This study is the first to show that, in human SLE, impaired sensitivity of Tresp cells to the suppressive effects of a comparably functional, highly purified nTreg cell population leads to a defective suppression of T cell proliferation in active SLE. Studies aiming to define the mechanisms leading to Tresp cell resistance might help in the development of highly specific, alternative immunotherapeutic tools for the control of systemic autoimmune diseases such as SLE. 相似文献
39.
R. Eckstein W. Mempel M. U. Heim A. Schleifer U. Mangold W. Wilmanns 《Annals of hematology》1985,50(4):233-241
Summary Indicator cells — tanned, surface stabilized sheep erythrocytes — were incubated for 1 h in supernatants of 3 h MLCs. Their electrophoretic mobility was measured by an analytical, carrier free electrophoresis system. The change in their mobility compared with an appropriate control was calculated in per cent and correlated with the conventional measured MLR-cpm. The correlation of the two quantities is statistically highly significant (p<0.01). Furthermore, the difference of the electrophoretic mobility values of the group of HLA-D-identical and the groups of HLA-D-haploidentical or -different donors is significant beyond the 1 level (p<0.0005). Our method enables, therefore recognition of a positive or negative MLC after only 4 h. Typing for HLA-D-determinants seems to be possible. This could be of great importance for histocompatibility testing and organ transplantation. 相似文献
40.